Safety and Feasibility of CD19 Chimeric Antigen Receptor (CAR) T Cells In Adults with CD19 Positive Relapsed and Refractory Acute Lymphoblastic Leukemia or Lymphoma
عنوان الدراسة
Safety and Feasibility of CD19 Chimeric Antigen Receptor (CAR) T Cells In Adults with CD19 Positive Relapsed and Refractory Acute Lymphoblastic Leukemia or Lymphoma
داعم الدراسة
KAIMRC
دواء الدراسة
CD19-CART
رقم بروتوكول الدراسة
RC20/446/R
حالة الدراسة
Completed
موقع الدراسة
NGHA-R
مرحلة الدراسة
1b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.